The global heart valve repair and replacement market is expected to reach USD 11,585.65 million by 2031 from 5,485.39 million in 2024, growing with a substantial CAGR of 11.3% in the forecast period of 2024 to 2031.
Market Segmentation
Global Heart Valve Repair And Replacement Market, By Product (Surgical Heart Valves Replacement, Surgical Heart Valve Repair, Tavi / Tavr Valves, Grafts, Patches, Medication, and Others), Procedure (Surgical Procedure and Non-Surgical Procedure), Indication (Valvular Stenosis, Valvular Insufficiency, Mitral Valve Prolapse, and Others), End User (Hospital, Specialty Centers, Cardiac Catheterization Lab, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Switzerland, Spain, Russia, Turkey, Belgium, Netherlands, Rest of Europe, China, India, South Korea, Japan, Thailand, Australia, Singapore, Indonesia, Malaysia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031.
Overview of Global Heart Valve Repair and Replacement Market Dynamics
- Driver
- Rise in incidence of valvular heart defects
- Restraint
- High cost associated with cardiovascular disease treatment
- Opportunity
- Rise in demand for minimally invasive technology
Market Players
Some of the key players operating in the global heart valve repair and replacement market are:
- MVRx, Inc.
- MeKo Laser Material Processing
- Comed B.V.
- CardiaMed
- Xeltis
- Foldax, Inc.
- JenaValve Technology, Inc.
- Colibri Heart Valve
- HLT, Inc.
- NeoChord, Inc.
- Meril Life Sciences Pvt. Ltd.
- Micro Interventional Devices, Inc.
- Biotronik
- Medtronic
- Abbott
- Neovasc Inc.
- Edwards Lifesciences Corporation
TABLE OF CONTENTS
1 INTRODUCTION 50
- 1.1 OBJECTIVES OF THE STUDY 50
- 1.2 MARKET DEFINITION 50
- 1.3 OVERVIEW OF GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET 50
- 1.4 LIMITATIONS 52
- 1.5 MARKETS COVERED 52
2 MARKET SEGMENTATION 55
- 2.1 MARKETS COVERED 55
- 2.2 GEOGRAPHICAL SCOPE 56
- 2.3 YEARS CONSIDERED FOR THE STUDY 57
- 2.4 CURRENCY AND PRICING 57
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 58
- 2.6 MULTIVARIATE MODELLING 61
- 2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 62
- 2.8 DBMR MARKET POSITION GRID 63
- 2.9 MARKET END USER COVERAGE GRID 64
- 2.10 VENDOR SHARE ANALYSIS 65
- 2.11 SECONDARY SOURCES 66
- 2.12 ASSUMPTIONS 66
3 EXECUTIVE SUMMARY 67
4 PREMIUM INSIGHTS 69
5 REIMBURSEMENT SCENARIO FOR HEART VALVE REPAIR AND REPLACEMENT 72
6 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET: REGULATIONS 77
- 6.1 REGULATIONS IN THE U.S. 77
- 6.2 REGULATIONS IN EUROPE 78
- 6.3 REGULATIONS IN CHINA 78
- 6.4 REGULATIONS IN INDIA 79
7 MARKET OVERVIEW 80
- 7.1 DRIVERS 82
- 7.1.1 RISE IN INCIDENCE OF VALVULAR HEART DEFECTS 82
- 7.1.2 INCREASE IN THE GERIATRIC POPULATION 82
- 7.1.3 FAVORABLE HEALTHCARE REIMBURSEMENT POLICIES 83
- 7.1.4 INCREASING TECHNOLOGICAL ADVANCEMENTS IN HEALTHCARE SECTOR 84
- 7.2 RESTRAINTS 85
- 7.2.1 HIGH COST ASSOCIATED WITH CARDIOVASCULAR DISEASE TREATMENT 85
- 7.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT 85
- 7.3 OPPORTUNITIES 87
- 7.3.1 RISE IN THE OBESE POPULATION GLOBALLY 87
- 7.3.2 RISE IN DEMAND FOR MINIMALLY INVASIVE TECHNOLOGY 88
- 7.3.3 RISING GOVERNMENT EXPENDITURE ON THE HEALTHCARE SECTOR 88
- 7.4 CHALLENGES 89
- 7.4.1 STRINGENT RULES AND REGULATIONS FOR GOVERNMENT APPROVAL IN THE HEALTHCARE SECTOR 89
8 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET, BY PRODUCT 90
- 8.1 OVERVIEW 91
- 8.2 SURGICAL HEART VALVE REPLACEMENT 92
- 8.2.1 SURGICAL HEART VALVE REPLACEMENT, BY PRODUCT 93
- 8.2.1.1 AORTIC, BY PRODUCT 93
- 8.2.1.2 TISSUE VALVE, BY PRODUCT 93
- 8.2.1.2.1 TISSUE VALVE, BY TYPE 94
- 8.2.1.3 AORTIC, BY TYPE 94
- 8.2.1.4 MITRAL, BY PRODUCT 94
- 8.2.1.4.1 TISSUE VALVE, BY TYPE 95
- 8.3 SURGICAL HEART VALVE REPAIR 95
- 8.3.1 SURGICAL HEART VALVE REPAIR, BY PRODUCT 95
- 8.3.1.1 MITRAL, BY PRODUCT 96
- 8.3.1.2 RINGS, BY TYPE 96
- 8.4 TAVI / TAVR VALVE 96
- 8.5 GRAFTS 97
- 8.6 PATCHES 97
- 8.7 MEDICATION 98
- 8.8 OTHERS 98
9 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET, BY PROCEDURE 99
- 9.1 OVERVIEW 100
- 9.2 SURGICAL PROCEDURE 101
- 9.2.1 SURGICAL PROCEDURE, BY PROCEDURE 101
- 9.2.1.1 HEART VALVE REPLACEMENT, BY PROCEDURE 101
- 9.2.1.2 HEART VALVE REPAIR, BY PROCEDURE 102
- 9.3 NON-SURGICAL PROCEDURE 103
10 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET, BY INDICATION 104
- 10.1 OVERVIEW 105
- 10.2 VALVULAR STENOSIS 106
- 10.2.1 VALVULAR STENOSIS, BY TYPE 106
- 10.3 VALVULAR INSUFFICIENCY 107
- 10.3.1 VALVULAR INSUFFICIENCY, BY TYPE 107
- 10.4 MITRAL VALVE PROLAPSE 108
- 10.5 OTHERS 108
11 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET, BY END USER 109
- 11.1 OVERVIEW 110
- 11.2 HOSPITAL 111
- 11.3 AMBULATORY SURGICAL CENTERS 112
- 11.4 SPECIALTY CENTERS 112
- 11.5 CARDIAC CATHETERIZATION LAB 113
- 11.6 OTHERS 113
12 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET, BY DISTRIBUTION CHANNEL 114
- 12.1 OVERVIEW 115
- 12.2 DIRECT TENDER 116
- 12.3 RETAIL SALES 117
- 12.4 OTHERS 117
13 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET, BY REGION 118
- 13.1 OVERVIEW 119
- 13.2 NORTH AMERICA 122
- 13.2.1 U.S. 130
- 13.2.2 CANADA 136
- 13.2.3 MEXICO 142
- 13.3 EUROPE 147
- 13.3.1 GERMANY 155
- 13.3.2 FRANCE 160
- 13.3.3 U.K. 166
- 13.3.4 BELGIUM 172
- 13.3.5 ITALY 178
- 13.3.6 SPAIN 184
- 13.3.7 RUSSIA 190
- 13.3.8 TURKEY 196
- 13.3.9 NETHERLANDS 201
- 13.3.10 SWITZERLAND 207
- 13.3.11 REST OF EUROPE 213
- 13.4 ASIA-PACIFIC 214
- 13.4.1 JAPAN 222
- 13.4.2 CHINA 227
- 13.4.3 SOUTH KOREA 233
- 13.4.4 INDIA 239
- 13.4.5 AUSTRALIA 245
- 13.4.6 SINGAPORE 250
- 13.4.7 THAILAND 256
- 13.4.8 MALAYSIA 262
- 13.4.9 INDONESIA 268
- 13.4.10 PHILIPPINES 274
- 13.4.11 REST OF ASIA-PACIFIC 280
- 13.5 SOUTH AMERICA 281
- 13.5.1 BRAZIL 289
- 13.5.2 ARGENTINA 294
- 13.5.3 REST OF SOUTH AMERICA 299
- 13.6 MIDDLE EAST AND AFRICA 300
- 13.6.1 SOUTH AFRICA 308
- 13.6.2 SAUDI ARABIA 314
- 13.6.3 UAE 320
- 13.6.4 EGYPT 326
- 13.6.5 ISRAEL 332
- 13.6.6 REST OF MIDDLE EAST AND AFRICA 338
14 GLOBAL HEART VALVE REPAIR AND REPLACEMENT MARKET: COMPANY LANDSCAPE 339
- 14.1 COMPANY SHARE ANALYSIS: GLOBAL 339
- 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 340
- 14.3 COMPANY SHARE ANALYSIS: EUROPE 341
- 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 342
15 SWOT ANALYSIS 343
16 COMPANY PROFILES 344
- 16.1 ABBOTT 344
- 16.1.1 COMPANY SNAPSHOT 344
- 16.1.2 REVENUE ANALYSIS 344
- 16.1.3 COMPANY SHARE ANALYSIS 345
- 16.1.4 PRODUCT PORTFOLIO 345
- 16.1.5 RECENT DEVELOPMENTS 346
- 16.2 EDWARDS LIFESCIENCES CORPORATION 347
- 16.2.1 COMPANY SNAPSHOT 347
- 16.2.2 REVENUE ANALYSIS 347
- 16.2.3 COMPANY SHARE ANALYSIS 348
- 16.2.4 PRODUCT PORTFOLIO 348
- 16.2.5 RECENT DEVELOPMENTS 349
- 16.3 MEDTRONIC 350
- 16.3.1 COMPANY SNAPSHOT 350
- 16.3.2 REVENUE ANALYSIS 350
- 16.3.3 COMPANY SHARE ANALYSIS 351
- 16.3.4 PRODUCT PORTFOLIO 351
- 16.3.5 RECENT DEVELOPMENTS 352
- 16.4 BIOTRONIK 353
- 16.4.1 COMPANY SNAPSHOT 353
- 16.4.2 PRODUCT PORTFOLIO 353
- 16.4.3 COMPANY SHARE ANALYSIS 353
- 16.4.4 RECENT DEVELOPMENT 353
- 16.5 MERIL LIFE SCIENCES PVT. LTD. 354
- 16.5.1 COMPANY SNAPSHOT 354
- 16.5.2 COMPANY SHARE ANALYSIS 354
- 16.5.3 PRODUCT PORTFOLIO 355
- 16.5.4 RECENT DEVELOPMENT 355
- 16.6 CARDIAMED 356
- 16.6.1 COMPANY SNAPSHOT 356
- 16.6.2 PRODUCT PORTFOLIO 356
- 16.6.3 RECENT DEVELOPMENT 356
- 16.7 COMED B.V. 357
- 16.7.1 COMPANY SNAPSHOT 357
- 16.7.2 PRODUCT PORTFOLIO 357
- 16.7.3 RECENT DEVELOPMENT 357
- 16.8 COLIBRI HEART VALVE 358
- 16.8.1 COMPANY SNAPSHOT 358
- 16.8.2 PRODUCT PORTFOLIO 358
- 16.8.3 RECENT DEVELOPMENT 358
- 16.9 FOLDAX, INC. 359
- 16.9.1 COMPANY SNAPSHOT 359
- 16.9.2 PRODUCT PORTFOLIO 359
- 16.9.3 RECENT DEVELOPMENTS 359
- 16.10 HLT, INC. 361
- 16.10.1 COMPANY SNAPSHOT 361
- 16.10.2 PRODUCT PORTFOLIO 361
- 16.10.3 RECENT DEVELOPMENT 361
- 16.11 JENAVALVE TECHNOLOGY, INC. 362
- 16.11.1 COMPANY SNAPSHOT 362
- 16.11.2 PRODUCT PORTFOLIO 362
- 16.11.3 RECENT DEVELOPMENT 362
- 16.12 MEKO LASER MATERIAL PROCESSING 363
- 16.12.1 COMPANY SNAPSHOT 363
- 16.12.2 PRODUCT PORTFOLIO 363
- 16.12.3 RECENT DEVELOPMENTS 363
- 16.13 MICRO INTERVENTIONAL DEVICES, INC. 364
- 16.13.1 COMPANY SNAPSHOT 364
- 16.13.2 PRODUCT PORTFOLIO 364
- 16.13.3 RECENT DEVELOPMENT 364
- 16.14 MVRX, INC. 365
- 16.14.1 COMPANY SNAPSHOT 365
- 16.14.2 PRODUCT PORTFOLIO 365
- 16.14.3 RECENT DEVELOPMENTS 365
- 16.15 NEOCHORD, INC. 366
- 16.15.1 COMPANY SNAPSHOT 366
- 16.15.2 PRODUCT PORTFOLIO 366
- 16.15.3 RECENT DEVELOPMENTS 367
- 16.16 NEOVASC, INC. 368
- 16.16.1 COMPANY SNAPSHOT 368
- 16.16.2 REVENUE ANALYSIS 368
- 16.16.3 PRODUCT PORTFOLIO 369
- 16.16.4 RECENT DEVELOPMENTS 369
- 16.17 XELTIS 370
- 16.17.1 COMPANY SNAPSHOT 370
- 16.17.2 PRODUCT PORTFOLIO 370
- 16.17.3 RECENT DEVELOPMENTS 370
17 QUESTIONNAIRE 372
18 RELATED REPORTS 377